| 6PPD-Q | 6-(N-phenyl-p-phenylenediamine) quinone |
| PPD | p-Phenylenediamine |
| PPD-Qs | p-Phenylenediamine quinones |
| cAMP | Cyclic adenosine monophosphate |
| BDNF | Brain-derived neurotrophic factor |
| GPCRs | G protein-coupled receptors |
| AC | Adenylyl cyclase |
| PDEs | Phosphodiesterases |
| ADORA2A | Adenosine A2A receptor |
| BBB | Blood-brain barrier |
| CNS | Central nervous system |
| SPF | Specific pathogen-free |
| EPM | Elevated plus maze |
| OFT | Open field test |
| UPLC-MS/MS | Ultra-performance liquid chromatography-tandem mass spectrometry |
| TEM | Transmission electron microscopy |
| H&E | Hematoxylin and eosin |
| FJB | Fluoro-Jade B |
| DAPI | 4′,6-Diamidino-2-phenylindole |
| qRT-PCR | Quantitative real-time polymerase chain reaction |
| PCA | Principal component analysis |
| DEGs | Differentially expressed genes |
| GO | Gene Ontology |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| GSEA | Gene Set Enrichment Analysis |
| PDB | Protein Data Bank |
| RMSD | Root-mean-square deviation |
| RMSF | Root-mean-square fluctuation |
| Rg | Radius of gyration |
| SASA | Solvent-accessible surface area |
| FEL | Free energy landscape |
| MIE | Molecular initiating event |
| AOP | Adverse outcome pathway |
| N2a | Neuro-2a |
| MEM | Minimum Essential Medium |
| FBS | Fetal bovine serum |
| DMSO | Dimethyl sulfoxide |
| ELISA | Enzyme-linked immunosorbent assay |
| BCA | Bicinchoninic acid |
| SDS-PAGE | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
| TBST | Tris-buffered saline with Tween 20 |
| ANOVA | Analysis of variance |
| LSD | Least significant difference |
| SD | Standard deviation |